News &amp; Updates

Original New Drug Application Approvals by US FDA (16-31 July 2023)

New drug applications approved by US FDA as of 16-31 July 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 July 2023)

Endometriosis not a risk factor for type 2 diabetes

The presence of endometriosis does not appear to contribute to an increased risk of type 2 diabetes in women, according to a study.

Endometriosis not a risk factor for type 2 diabetes

02 Aug 2023

PPI use carries increased risk of pneumonia

Individuals who use proton pump inhibitors (PPIs) appear to be at heightened risk of pneumonia, as reported in a study.

PPI use carries increased risk of pneumonia

Common glucose-lowering drug may also work to prevent muscle atrophy in older adults

For older people, administering metformin before or during a period of reduced physical activity appears to have potential benefits for the muscles, such as reducing atrophy and improving recovery, as reported by a team of US-based researchers.

Common glucose-lowering drug may also work to prevent muscle atrophy in older adults

Sight-threatening eye diseases tied to higher risk of suicide death

In South Korea, the rate of suicide is particularly increased among individuals diagnosed with sight-threatening eye disease (STED) between 2010 and 2020, reveals a study.

Sight-threatening eye diseases tied to higher risk of suicide death

Physical activity offsets downsides of abnormal sleep duration

Short and long sleep durations were tied to higher risks for all-cause, cardiovascular disease (CVD), and cancer mortality, but these may be attenuated by engaging in physical activity (PA), a population-based cohort study suggests.

Physical activity offsets downsides of abnormal sleep duration

01 Aug 2023

COVID-19 vaccines may elicit cross-reactive T-cell responses for long-term protection

Researchers from the Chinese University of Hong Kong (CUHK) have reported that two doses of either mRNA-based BNT162b2 or inactivated CZ02 vaccine elicit cross-reactive T-cell responses. Identification of vaccine-induced memory T cells indicates potential long-term protection with COVID-19 vaccines.

COVID-19 vaccines may elicit cross-reactive T-cell responses for long-term protection

01 Aug 2023

Air pollution a hazard to pregnant women and their babies

Exposure to traffic-related air pollution may put pregnant women at risk of delivering preterm and the babies at risk of neonatal intensive care unit (NICU) admissions and low birthweight, among others, as reported in a study.

Air pollution a hazard to pregnant women and their babies

Novel oral IL-23R antagonist improves skin lesions in patients with plaque psoriasis

Treatment with JNJ-77242113, an oral interleukin-23 receptor (IL-23R) antagonist peptide, leads to significant improvement in skin lesions, as measured by the Psoriasis Area and Severity Index (PASI) scores, in patients with moderate-to-severe plaque psoriasis, according to the FRONTIER 1 study presented at WCD 2023.

Novel oral IL-23R antagonist improves skin lesions in patients with plaque psoriasis